Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs Veritone Inc (VERI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs Veritone Inc — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.65 (market cap $2.27B), while Veritone Inc trades at $0.56 (market cap $59.46M). The key difference: SELLAS Life Sciences Group Inc. Common Stock is far larger — about 38.2× Veritone Inc's market cap, and SELLAS Life Sciences Group Inc. Common Stock is trading nearer its 52-week high, Veritone Inc nearer its low. Which is the better fit depends on your goals.
| SLS | VERI | |
|---|---|---|
Market Cap | $2.27B | $59.46M |
Volume | 4,179,659 | 15,523,164 |
Sector | Health | Technology |
52-Week High | $15.46 | $8.39 |
52-Week Low | $1.39 | $0.59 |
Enterprise Value | $2.14B | $94.86M |
Typical Hold Time | — | 12 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Veritone (VERI) trades at $0.5851, down 15.36% in the past 24 hours, reflecting significant bearish pressure. The company shows concerning fundamentals with a net income margin of -117.54% and negative ROE of -547.67% for 2025, though it maintains a gross margin of 66.2%. Recent developments include a $15 million equity offering and partnerships with ATP Media and ZeroEyes, while facing securities class action investigations. Technical indicators show mixed signals with bearish moving averages but bullish oscillators.
The outlook remains challenging with persistent losses and negative cash flow from operations, though analyst consensus suggests upside potential with a $3.75 price target. Key risks include ongoing legal scrutiny, execution challenges in achieving profitability, and competitive pressures in the AI solutions space. The stock presents high-risk speculative potential for investors betting on turnaround execution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About Veritone Inc
Veritone is a leading provider of enterprise AI software and solutions, centered on its proprietary AI operating system, aiWARE™. The platform orchestrates a vast ecosystem of machine learning models to transform unstructured data—such as audio, video, and text—into actionable intelligence. Serving the media, entertainment, and public sectors, Veritone is a critical infrastructure partner for organizations looking to monetize data archives and operationalize AI at scale.
Read more on VERI →
